Cell Viability Assays and Consumables: Global Markets

Summary

Cell viability assays refer to a homogeneous method to determine the number of viable cells within a culture. Cell viability measurements are used to evaluate the effectiveness of a drug candidate, rejection of implanted organs or evaluation of the life or death of cancerous cells. Cell viability assays are used in clinical and diagnostic applications, drug discovery and development, stem cell research, basic research and other applications such as toxicity testing and tissue engineering. Cell viability assays have proven to be extremely beneficial in drug discovery applications and the global cell viability assays market is projected to see rapid growth during the forecast period (2018-2023) owing to increasing emphasis on stem cell research and increasing demand for cell-based assays in research and development.

A surge in the number of potential biomarkers candidates for cell-based assays, growing incidence of infectious and chronic diseases and increasing focus on developing cell-based therapeutics are some of the major factors that are expected to promote the growth of global cell viability assays market. In addition, factors such as increasing healthcare expenditures and the global aging population are also providing traction for the global cell viability assays market growth during the forecast period. The growing prevalence of infectious and chronic diseases is considered to be the major driver behind the growth of the cell viability assays market. Cell viability measurements are used to evaluate the
effectiveness of a drug candidate, rejection of implanted organs or the life or death of cancerous cells.

According to the World Health Organization (WHO), the number of patients suffering from chronic diseases such as respiratory disease, cancer and cardiovascular disease totaled about 130 million people in 2005 and is expected to reach REDACTED by 2030. In addition, increasing emphasis on stem cell research is also poised to generate strong growth opportunities for cell viability assays. Governments globally are investing huge amounts on stem cell research. According to the U.S. Department of Health and Human Services, REDACTED billion was spent on stem cell research in 2016; this increased to REDACTED in 2017. In April 2017, Bayer AG and Versant Ventures (U.S.) announced plans to invest REDACTED to launch a stem cell research company in Canada and create a global hub for regenerative-medicinetherapies.

The global cell viability assays market is projected to rise at a compound annual growth rate (CAGR) of REDACTED during the forecast period of 2018 through 2023. Market value is expected to rise from REDACTED in 2018 to REDACTED by 2023. Consumables held REDACTED of the market in 2017 in terms of revenue. By 2023, total revenue from consumables is expected to see a CAGR of REDACTED.

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Introduction
Market Potential
Market Size and Growth
Consumer Types and Product Success
Competitor Pricing
Regulatory Framework
United States
European Union
China
India
Japan
Australia
Brazil
Russia
Investment Analysis
Industry Growth Drivers
Increasing Focus on Development of Cell-Based Therapeutics and Potential Biomarkers
Growing Prevalence and Incidence of Infectious and Chronic Diseases
Increasing Demand for Cell-Based Assays in Research and Development
Increasing Emphasis on Stem Cell Research
Chapter 4 Cell Viability Assays Market by Product
Instruments
Automated Cell Counters
Flow Cytometers
Spectrophotometers
Cell Imaging and Analysis Systems
Consumables
Reagents
Assay Kits
Microplates
Chapter 5 Market Breakdown by Cell Type
Human Cells
Assays to Measure Viable Cells
Benefits of Protease Marker Assays
Advantages of ATP Assays
ATP Cell Viability Assay for Measuring Intrinsic Radio-Sensitivity in Cervical Cancer
Animal Cells
Advantages of Viability Assays for Animals
Microbial Cells
Cell Viability Assay to Determine the Cytotoxic Effects by Microbes in Water
Imaging Microbial Viability Assays
Imaging Biofilm Viability Assays
Bacterial Viability Assays for Flow Cytometry
Viability Detection of Foodborne Microbial Pathogens
Global Estimates of Foodborne Diseases
Chapter 6 Market Breakdown by Application
Clinical and Diagnostic Applications
Drug Discovery and Development
Stem Cell Research
Potential Benefits of Stem Cell Research
Basic Research
Other Applications (e.g., Toxicity Testing, Tissue Engineering)
Toxicity Testing
Tissue Engineering
Chapter 7 Market Breakdown by End User
Academic and Research Institutions
Market Drivers
Pharmaceutical and Biotechnology Companies
UV-Spectrophotometers for Drug Stability Testing
Market Drivers
Hospitals and Diagnostic Laboratories
Cell Viability Assays
Assays and Their Substrates
Technological Advancements and Innovations
XTT Formazan Assay to Detect Cell Viability Inhibits HIV Type 1 Infection
Viability Assay to Identify Biologically-Relevant Malaria Transmission- Blocking Drugs
Assays for Diagnostic Tests for Malaria
Non-Blood Based Assays
Blood-Based Assays
Other End Users
Cancer Diagnosis and Prognosis
Chapter 8 Market Breakdown by Region
North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific Region
China
Japan
India
Australia
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East and Africa
Chapter 9 Cell Viability Assays Market Industry Structure
Raw Material Suppliers
Quality and Technology
Terms and Conditions
Cost-Effective Components
Manufacturers
Distributors
Raw Material Suppliers of Consumables
Quality
Terms and Conditions
Cost
Manufacturers of Consumables
Distributors of Consumables
End Users of Consumables
Innovation Within the Industry
Competitive Analysis
Chapter 10 Company Profiles
AAT BIOQUEST INC.
ABCAM
ABNOVA CORP.
ANASPEC INC.
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES
BIOTEK INSTRUMENTS
BIOTIUM
BIOVISION INC.
CAYMAN CHEMICAL
CORNING INC.
CREATIVE BIOARRAY
DANAHER CORP.
DOJINDO MOLECULAR TECHNOLOGIES INC.
GE HEALTHCARE
INTELLICYT CORP.
MERCK KGAA
MESGEN
MOLECULAR DEVICES LLC
PERKINELMER
PROMEGA CORP.
RandD SYSTEMS INC.
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC
VITASCIENTIFIC

List Of Tables


Summary Table : Global Cell Viability Assays Market, by Product, Through 2023
Table 1 : Manufacturer and Distributor Product Pricing Comparison
Table 2 : Examples of Requirements for UV-Visible Spectrophotometers
Table 3 : Classes of Biologicals
Table 4 : Cell Viability Assay Market: Key Recent Investments
Table 5 : Recent Studies in Cell-Based Therapeutics
Table 6 : NIH Funding Estimates for Various Conditions and Diseases, 2014-2019
Table 7 : Leading Causes of Burden of Diseases around the World, 2004 and 2030
Table 8 : Worldwide Cancer Incidence Rate, 2018
Table 9 : Global Pharmaceutical RandD Spending, 2015-2022
Table 10 : Pharmaceutical Research and Manufacturers of America Member Company RandD Expenditures, 2010 and 2016
Table 11 : Investments in Stem Cell Research
Table 12 : Global Cell Viability Assays Market, by Product, Through 2023
Table 13 : Global Cell Viability Assays Instruments Market, by Type, Through 2023
Table 14 : Global Cell Viability Assays Instruments Market, by Region, Through 2023
Table 15 : Global Automated Cell Counters Market, by Region, Through 2023
Table 16 : Global Flow Cytometers Market, by Region, Through 2023
Table 17 : Feature-wise Comparison of Conventional Flow Cytometry and Imaging Flow Cytometry
Table 18 : Key Analytical Parameters Measured by Flow Cytometers in Cell Viability Research
Table 19 : Global Spectrophotometers Market, by Region, Through 2023
Table 20 : Types of Spectrophotometers for Cell Viability Analysis
Table 21 : Global Cell Imaging and Analysis Systems Market, by Region, Through 2023
Table 22 : Global Cell Viability Assays Consumables Market, by Type, Through 2023
Table 23 : Global Cell Viability Assays Consumables Market, by Region, Through 2023
Table 24 : Global Reagents Market, by Region, Through 2023
Table 25 : Library Screening of Small-Molecule Cancer Cells by Deploying Real-Time Cell Viability Assays
Table 26 : List of Applications of Reagents for Drug Discovery
Table 27 : List of Research Laboratories Using Reagents for Cell Viability Testing
Table 28 : Global Assay Kits Market, by Region, Through 2023
Table 29 : Global Assay kits Market, by Type, Through 2023
Table 30 : MTT and XTT Kits Comparison
Table 31 : Cost-effective Cell Viability Assays Through In Vitro Cell Screening and Cell Death Discrimination
Table 32 : Procedure for Quantification of Cell Number Through MTT Assays
Table 33 : Key Benefits and Features of XTT Assay Kits Over Radioactive Isotope Techniques
Table 34 : List of Recently-Developed Chymotrypsin and Homogeneous Trypsin Protease Assays, 2017
Table 35 : Global Microplates Market, by Region, Through 2023
Table 36 : Funding for Various Projects in Life Sciences Research, 2017-2026
Table 37 : Innovation Project Funds for BRAIN 2025 Priority Verticals
Table 38 : Global Cell Viability Assays Market, by Cell Type, Through 2023
Table 39 : Global Human Cells Market, by Region, Through 2023
Table 40 : Rate of New Cancer Cases, 2018
Table 41 : Global Deaths Due to Cancer, 2018
Table 42 : Global Oncology Therapeutics Investment, 2011-2021
Table 43 : Global Animal Cells Market, by Region, Through 2023
Table 44 : Intracellular Assays to Measure Cellular Proliferation
Table 45 : Global Microbial Cells Market, by Region, Through 2023
Table 46 : Regional Foodborne Disease, 2016
Table 47 : Global Cell Viability Assays Market, by Application, Through 2023
Table 48 : Global Clinical and Diagnostic Applications Market, by Region, Through 2023
Table 49 : Global Cancer Burden, 2012 and 2030
Table 50 : Global Prevalence of Dementia, 2015-2050
Table 51 : Global Pharmaceutical Market, 2015 and 2020
Table 52 : Pharmaceutical Spending as a Percentage of Health Spending, by Country, 2016
Table 53 : Global Biologics Spending, 2011 and 2016
Table 54 : Global Drug Discovery and Development Market, by Region, Through 2023
Table 55 : Global Total Pharmaceutical RandD Spending, 2015-2022
Table 56 : Description of Government Support for Development of New Treatments in Organizations, by Country
Table 57 : Global Stem Cell Research Market, by Region, Through 2023
Table 58 : Application of Stem Cells in Regenerative Medicines
Table 59 : NIH Spending on Stem Cell Research, 2014-2018 (Estimated)
Table 60 : Growing Investment in Different Areas of Stem Cell-Based Research in the United States, 2016 and 2017
Table 61 : Ongoing Clinical Diabetes-Based Stem Cell Research
Table 62 : Ongoing Clinical Leukemia-Based Stem Cell Research
Table 63 : Global Basic Research Market, by Region, Through 2023
Table 64 : Top U.S. Academic Institutions Spending on RandD, 2018
Table 65 : Global Others Application Market, by Region, Through 2023
Table 66 : Funded Projects Supporting Tissue Engineering Solutions in Cancer Research
Table 67 : Global Cell Viability Assays Market, by End User, Through 2023
Table 68 : Global Academic and Research Institutions Market, by Region, Through 2023
Table 69 : Current Cancer Research Grants, by Type, 2018
Table 70 : Global Pharmaceutical and Biotechnology Companies Market, by Region, Through 2023
Table 71 : Pharmaceutical RandD Spending by U.S., 2005-2015
Table 72 : RandD Spending by Seven Pharma Giants in India, 2016
Table 73 : Global Hospital and Diagnostic Laboratories in Cell Viability Assays Market, by Region, Through 2023
Table 74 : Death Rates Due to Cancer, 2018
Table 75 : People Infected with HIV, by Region, 2014-2016
Table 76 : Malaria Deaths, by Region, 2014-2016
Table 77 : Global Others End User Market, by Region, Through 2023
Table 78 : Clinical Applications of Flow Cytometry
Table 79 : Various Cancer Research Programs
Table 80 : Selected Fluorescent Dyes for Specific Staining in Flow Cytometry Applications in Food Microbiology
Table 81 : Global Cell Viability Assays Market, by Region, Through 2023
Table 82 : North American Cell Viability Assays Market, by Country, Through 2023
Table 83 : North American Cell Viability Assays Market, by Type, Through 2023
Table 84 : North American Cell Viability Assays Market, by Application, Through 2023
Table 85 : North American Cell Viability Assays Market, by End User, Through 2023
Table 86 : North American Cell Viability Assays Market, by Product, Through 2023
Table 87 : NIH Spending on Stem Cell Research, 2013-2016
Table 88 : Healthcare Expenditures in Canada, 2015 and 2040
Table 89 : Distribution of Annual Budget of Canadian Institutes of Health Research, 2016
Table 90 : European Cell Viability Assays Market, by Country, Through 2023
Table 91 : European Cell Viability Assays Market, by Product, Through 2023
Table 92 : European Cell Viability Assays Market, by End User, Through 2023
Table 93 : European Cell Viability Assays Market, by Type, Through 2023
Table 94 : European Cell Viability Assays Market, by Application, Through 2023
Table 95 : Estimated Number of People Living with Cancer, 2015 and 2020
Table 96 : Deaths from and Number of People Living with Heart and Circulatory Diseases in the United Kingdom, 2016
Table 97 : Government Funding for Drug-Based Research in France, 2010 and 2016
Table 98 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Table 99 : Hospitals and Research Centers Participating in Clinical Trials on Cancer, 2004-2016
Table 100 : Rising Prevalence of Breast Cancer in Norway, 2014 and 2015
Table 101 : Asia-Pacific Cell Viability Assays Market, by Country, Through 2023
Table 102 : Asia-Pacific Cell Viability Assays Market, by Product, Through 2023
Table 103 : Asia-Pacific Cell Viability Assays Market, by Type, Through 2023
Table 104 : Asia-Pacific Cell Viability Assays Market, by End User, Through 2023
Table 105 : Asia-Pacific Cell Viability Assays Market, by Application, Through 2023
Table 106 : Number of People with Cancer in China, 2010-2016
Table 107 : Growth in Japanese Pharmaceuticals Industry, 2010-2015
Table 108 : RandD Spending by Top Seven Pharmaceutical Companies in India, 2016
Table 109 : Overall ROW RandD Expenditures, by Region, 2016 and 2017
Table 110 : Rest of the World Cell Viability Assays Market, by Region, Through 2023
Table 111 : Rest of the World Cell Viability Assays Market, by Application, Through 2023
Table 112 : Rest of the World Cell Viability Assays Market, by Type, Through 2023
Table 113 : Rest of the World Cell Viability Assays Market, by End User, Through 2023
Table 114 : Rest of the World Cell Viability Assays Market, by Product, Through 2023
Table 115 : Deaths in Brazil Due to Cancer, by Type, 2010 and 2016
Table 116 : Prevalence of Cancer in Brazil, by Type, 2010 and 2016
Table 117 : Capital Raised by Israeli High-Tech Companies, 2013-2017
Table 118 : Raw Material/Part Manufacturers
Table 119 : Manufacturers Operating in the Cell Assays Market
Table 120 : Distributors Operating in the Cell Assays Market
Table 121 : Raw Material/Part Manufacturers
Table 122 : Manufacturers Operating in the Cell Assays Market
Table 123 : Distribution of Cell Assays Studies Globally, 2018
Table 124 : Use of Competitive Strategies in the Global Cell Viability Assay Market, 2015 and 2018
Table 125 : AAT Bioquest Inc.: Product Portfolio
Table 126 : ABCAM: Product Portfolio
Table 127 : ABCAM: Recent Developments
Table 128 : Abnova: Product Portfolio
Table 129 : Abnova: Recent Developments, 2015-2018
Table 130 : AnaSpec Inc.: Product Portfolio
Table 131 : AnaSpec Inc.: Recent Developments
Table 132 : Becton, Dickinson and Co.: Product Portfolio
Table 133 : Becton, Dickinson and Co.: Recent Developments
Table 134 : Bio-Rad Laboratories: Product Portfolio
Table 135 : Bio-Rad Laboratories: Recent Developments
Table 136 : BioTek Instruments Inc.: Product Portfolio
Table 137 : BioTek Instruments Inc.: Developments, April 2016-October 2018
Table 138 : Biotium: Product Portfolio
Table 139 : BioVision Inc.: Product Portfolio
Table 140 : Cayman Chemical: Product Portfolio
Table 141 : Cayman Chemical: Recent Developments
Table 142 : Corning Inc.: Product Portfolio
Table 143 : Creative Bioarray: Product Portfolio
Table 144 : Danaher Corp.: Product Portfolio
Table 145 : Danaher Corp.: Recent Developments
Table 146 : Dojindo Molecular Technologies Inc.: Product Portfolio
Table 147 : GE Healthcare: Product Portfolio
Table 148 : Intellicyt Corp.: Product Portfolio
Table 149 : Intellicyt Corp.: Recent Developments
Table 150 : Merck KGAA: Product Portfolio
Table 151 : Merck KGAA: Recent Developments
Table 152 : MesGen: Product Portfolio
Table 153 : Molecular Devices LLC: Product Portfolio
Table 154 : Molecular Devices LLC: Recent Developments
Table 155 : PerkinElmer Inc.: Product Portfolio
Table 156 : Promega Corp.: Product Portfolio
Table 157 : RandD Systems Inc.: Product Portfolio
Table 158 : Takara Bio Inc.: Product Portfolio
Table 159 : Takara Bio Inc.: Recent Developments
Table 160 : Thermo Fisher Scientific: Product Portfolio
Table 161 : VitaScientific: Product Portfolio

List Of Figures


Summary Figure : Global Cell Viability Assays Market, by Product, 2017-2023
Figure 1 : Research Funding for Biological Science Research Studies, 2017
Figure 2 : Global Tissue Engineering and Cell Therapy Market Growth, 2009-2018
Figure 3 : Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
Figure 4 : Worldwide Cancer Incidence Rate, by Type, 2018
Figure 5 : Global Pharmaceutical RandD Spending, 2015-2022
Figure 6 : Pharmaceutical Research and Manufacturers of America Member Company RandD Expenditures, 2010 and 2016
Figure 7 : Cell Viability Assays Market, by Product
Figure 8 : Types of Automated Cell Counters
Figure 9 : dPCR used for Viability of Genetically Modified Organisms (GMOs)
Figure 10 : Types of Consumables in the Cell Viability Assays Market
Figure 11 : Classification of Assay kits
Figure 12 : Conversion of Resazurin to Resorufin to Determine Cell Viability
Figure 13 : Protease Activity Assays
Figure 14 : Global Deaths Due to Cancer, 2018
Figure 15 : Global Oncology Therapeutics Investment, 2011-2021
Figure 16 : Approaches for Bacterial Viability Assessment
Figure 17 : PMA-qPCR Assay and PMA treatment
Figure 18 : Major Growth Factors of Global Cell Viability Assays Market, by Application
Figure 19 : Cell Viability Assay Products Used in Clinical and Diagnostics Application
Figure 20 : Global Cancer Burden, 2012 and 2030
Figure 21 : Global Prevalence of Dementia, 2015-2050
Figure 22 : Evaluation of Cell Viability Using Flow Cytometry Technique
Figure 23 : Global Pharmaceutical Market, 2015 and 2020
Figure 24 : Pharmaceutical Spending as a Percentage of Health Spending, 2016
Figure 25 : Global Biologics Spending, 2011 and 2016
Figure 26 : Global Total of Pharmaceutical RandD Spending, 2015-2022
Figure 27 : Classification of Stem Cells
Figure 28 : NIH Spending on Stem Cell Research, 2014-2018 (Estimated)
Figure 29 : Growing Investment in Different Stem Cell-Based Research in the United States, 2016 and 2017
Figure 30 : Rise in RandD Expenditures in 2018 Compared with 2017
Figure 31 : Global Spending on Life Sciences RandD, 2015-2018
Figure 32 : Top RandD Spending Nations in Europe, 2017 and 2018
Figure 33 : Investment in Research and Innovation Through European Commission Framework Programs, 1984-2027
Figure 34 : Number of Research Grants Received by European Countries, 2018
Figure 35 : RandD Expenditures of the Top 20 Countries in Asia, 2017 and 2018
Figure 36 : Cell Viability Assays End Users
Figure 37 : Major Factors Driving Growth of the Cell Viability Assays Market
Figure 38 : Generalized Scheme Representing an In Vitro Cytotoxicity Assay Protocol
Figure 39 : Methods of Cell Viability Counting Used in Research Institutions
Figure 40 : Usage of Flow Cytometry in the Drug Discovery and Development Process
Figure 41 : U.S. Pharmaceutical RandD Spending, 2005-2015
Figure 42 : RandD Spending by Indias Seven Largest Pharma Companies, 2016
Figure 43 : Death Rates Due to Cancer, 2018
Figure 44 : People Infected with HIV, by Region, 2014-2016
Figure 45 : Malaria Deaths, by Region, 2014-2016
Figure 46 : NIH Spending on Stem Cell Research, 2013-2016
Figure 47 : Healthcare Expenditures in Canada, 2015 and 2040
Figure 48 : Distribution of Annual Budget of Canadian Institute of Health Research, 2016
Figure 49 : Estimated Number of People Living with Cancer in the U.K., 2015 vs. 2020
Figure 50 : Government Funding for Drug-Based Research in France, 2010 and 2016
Figure 51 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Figure 52 : Hospitals and Research Centers Participating in Clinical Trials on Cancer, 2004-2016
Figure 53 : Rising Prevalence of Breast Cancer in Norway, 2014 and 2015
Figure 54 : Number of People with Cancer in China, 2010-2016
Figure 55 : Japanese Pharmaceuticals Industry, 2010-2015
Figure 56 : RandD Spending by Top Seven Pharmaceutical Companies in India, 2018
Figure 57 : Overall ROW RandD Expenditures, by Region, 2016 and 2017
Figure 58 : Deaths in Brazil Due to Cancer, 2010 and 2016
Figure 59 : Capital Raised by Israeli High-Tech Companies, 2013-2017
Figure 60 : Industry Structure of Instruments Used in Cell Viability Assays Market
Figure 61 : Industry Structure of Consumables Used in the Cell Viability Assays Market
Figure 62 : Distribution of Cell Assays Studies Globally, 2018
Figure 63 : Competitive Strategies Used in the Global Cell Viability Assay Market, 2015 and 2018

Cell Therapy Biomanufacturing: Global Markets

This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region. market research report available in single user pdf license with Aarkstore Enterprise at USD 5500

USD 5500 View Report

COVID-19 Outbreak-Global Scaffold Free 3D Cell Culture Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The Scaffold Free 3D Cell Culture market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19

USD 3660 View Report

Europe Cell Viability Assays Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Cell Viability Assays market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

Asia Pacific Cell Viability Assays Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Cell Viability Assays market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available